{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:38:23Z","timestamp":1791297503524,"version":"4.1.0"},"reference-count":145,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T00:00:00Z","timestamp":1560902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01378","type":"journal-article","created":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T04:43:31Z","timestamp":1560919411000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["How Monocytes Contribute to Increased Risk of Atherosclerosis in Virologically-Suppressed HIV-Positive Individuals Receiving Combination Antiretroviral Therapy"],"prefix":"10.3389","volume":"10","author":[{"given":"Anthony","family":"Jaworowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna C.","family":"Hearps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Angelovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer F.","family":"Hoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,6,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S1473-3099(13)70692-3","article-title":"Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial","volume":"14","author":"Grinsztejn","year":"2014","journal-title":"Lancet Infect Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/QAI.0000000000001014","article-title":"Narrowing the gap in life expectancy between HIV-infected and HIV-uninfected individuals with access to care","volume":"73","author":"Marcus","year":"2016","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B3","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1089\/aid.2017.0284","article-title":"Early treatment of primary HIV infection is associated with decreased mortality","volume":"34","author":"Pinto","year":"2018","journal-title":"AIDS Res Hum Retroviruses."},{"key":"B4","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/QAI.0000000000001029","article-title":"Limiting cumulative HIV viremia copy-years by early treatment reduces risk of AIDS and death","volume":"73","author":"Olson","year":"2016","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e48839","DOI":"10.1371\/journal.pone.0048839","article-title":"Long-term survival in HIV positive patients with up to 15 Years of antiretroviral therapy","volume":"7","author":"McManus","year":"2012","journal-title":"PLoS ONE."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e349","DOI":"10.1016\/S2352-3018(17)30066-8","volume":"4","year":"2017","journal-title":"Lancet HIV."},{"key":"B7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s11883-017-0652-3","article-title":"HIV infection and risk of cardiovascular diseases beyond coronary artery disease","volume":"19","author":"Barnes","year":"2017","journal-title":"Curr Atheroscler Rep."},{"key":"B8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2174\/1573403X13666171129170046","article-title":"Cardiovascular disease in the setting of human immunodeficiency virus infection","volume":"14","author":"Pinto","year":"2018","journal-title":"Curr Cardiol Rev."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1097\/QAD.0000000000000222","article-title":"Causes of death among HIV-infected patients in France in 2010 (national survey): trends since 2000","volume":"28","author":"Morlat","year":"2014","journal-title":"AIDS."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1210\/jc.2006-2190","article-title":"Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease","volume":"92","author":"Triant","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"key":"B11","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1001\/jamainternmed.2013.3728","article-title":"HIV infection and the risk of acute myocardial infarction","volume":"173","author":"Freiberg","year":"2013","journal-title":"JAMA Intern Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1097\/QAD.0b013e328339192f","article-title":"Increased risk of myocardial infarction in HIV-infected patients in France, relative to the general population","volume":"24","author":"Lang","year":"2010","journal-title":"AIDS."},{"key":"B13","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1097\/QAI.0000000000001450","article-title":"Increased risk of myocardial infarction in HIV-infected individuals in north america compared with the general population","volume":"75","author":"Drozd","year":"2017","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1093\/cid\/civ014","article-title":"Declining relative risk for myocardial infarction among HIV-positive compared with HIV-negative individuals with access to care","volume":"60","author":"Klein","year":"2015","journal-title":"Clin Infect Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/QAI.0000000000000009","article-title":"Immunodeficiency and risk of myocardial infarction among HIV-positive individuals with access to care","volume":"65","author":"Silverberg","year":"2014","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B16","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/hiv.12616","article-title":"Decreasing rates of acute myocardial infarction in people living with HIV: a nationwide cohort study in Spain, 2004-2015","volume":"19","author":"Masia","year":"2018","journal-title":"HIV Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"335","DOI":"10.7326\/M14-0954","article-title":"Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: cross-sectional surveys","volume":"162","author":"Mdodo","year":"2015","journal-title":"Ann Intern Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1521\/aeap.2009.21.3_supp.106","article-title":"Cigarette smoking and HIV: more evidence for action","volume":"21","author":"Reynolds","year":"2009","journal-title":"AIDS Educ Prev."},{"key":"B19","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1513\/pats.201009-058WR","article-title":"Cigarette smoking in the HIV-infected population","volume":"8","author":"Rahmanian","year":"2011","journal-title":"Proc Am Thorac Soc."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1097\/01.aids.0000181011.62385.91","article-title":"Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the Multicenter AIDS Cohort Study","volume":"19","author":"Brown","year":"2005","journal-title":"AIDS."},{"key":"B21","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/QAI.0b013e31826bfc32","article-title":"Association of HIV infection with incident diabetes mellitus: impact of using hemoglobin A1C as a criterion for diabetes","volume":"61","author":"Tien","year":"2012","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1093\/cid\/ciu701","article-title":"Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study","volume":"59","author":"Schouten","year":"2014","journal-title":"Clin Infect Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/cid\/ciw285","article-title":"Higher Prevalence of hypertension in HIV-1-infected patients on combination antiretroviral therapy is associated with changes in body composition and prior stavudine exposure","volume":"63","author":"van Zoest","year":"2016","journal-title":"Clin Infect Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/cid\/ciw725","article-title":"Characteristics and outcomes of pediatric patients with ebola virus disease admitted to treatment units in liberia and sierra leone: a retrospective cohort study","volume":"64","author":"Smit","year":"2017","journal-title":"Clin Infect Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1016\/S2352-3018(18)30295-9","article-title":"Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies","volume":"6","author":"Althoff","year":"2019","journal-title":"Lancet HIV."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction","volume":"349","author":"Friis-Moller","year":"2003","journal-title":"N Engl J Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.ijantimicag.2018.07.010","article-title":"Risk of cardiovascular disease associated with exposure to abacavir among individuals with HIV: a systematic review and meta-analyses of results from 17 epidemiologic studies","volume":"52","author":"Dorjee","year":"2018","journal-title":"Int J Antimicrob Agents."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1097\/00002030-200311210-00010","article-title":"Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men","volume":"17","author":"Mary-Krause","year":"2003","journal-title":"AIDS."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e291","DOI":"10.1016\/S2352-3018(18)30043-2","article-title":"Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study","volume":"5","author":"Ryom","year":"2018","journal-title":"Lancet HIV."},{"key":"B30","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1080\/09540121.2010.543885","article-title":"Regional fat deposition and cardiovascular risk in HIV infection: the FRAM study","volume":"23","author":"Lake","year":"2011","journal-title":"AIDS Care."},{"key":"B31","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1097\/QAD.0b013e32834507f0","article-title":"High-density lipoprotein levels and 10-year cardiovascular risk in HIV-1-infected patients","volume":"25","author":"Cotter","year":"2011","journal-title":"AIDS."},{"key":"B32","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1161\/HYPERTENSIONAHA.118.10893","article-title":"Hypertension in HIV-infected adults: novel pathophysiologic mechanisms","volume":"72","author":"Fahme","year":"2018","journal-title":"Hypertension."},{"key":"B33","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/hiv.12639","article-title":"Association between exposure to antiretroviral drugs and the incidence of hypertension in HIV-positive persons: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study","volume":"19","author":"Hatleberg","year":"2018","journal-title":"HIV Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1097\/QAD.0b013e3282efad32","article-title":"Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection","volume":"21","author":"Wand","year":"2007","journal-title":"AIDS."},{"key":"B35","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1080\/15284336.2017.1311502","article-title":"Prevalence of metabolic syndrome in HIV-infected patients naive to antiretroviral therapy or receiving a first-line treatment","volume":"18","author":"Calza","year":"2017","journal-title":"HIV Clin Trials."},{"key":"B36","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1258\/095646207780132415","article-title":"Incidence and prevalence of the metabolic syndrome in a cohort of naive HIV-infected patients: prospective analysis at 48 weeks of highly active antiretroviral therapy","volume":"18","author":"Palacios","year":"2007","journal-title":"Int J STD AIDS."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1097\/QAD.0000000000000848","article-title":"Effects of abacavir administration on structural and functional markers of platelet activation","volume":"29","author":"Trevillyan","year":"2015","journal-title":"AIDS."},{"key":"B38","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1097\/QAD.0000000000001783","article-title":"Switching from abacavir to tenofovir disoproxil fumarate is associated with rises in soluble glycoprotein VI, suggesting changes in platelet-collagen interactions","volume":"32","author":"O'Halloran","year":"2018","journal-title":"AIDS."},{"key":"B39","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/cid\/cir324","article-title":"Peripheral and central fat changes in subjects randomized to abacavir-lamivudine or tenofovir-emtricitabine with atazanavir-ritonavir or efavirenz: ACTG study A5224s","volume":"53","author":"McComsey","year":"2011","journal-title":"Clin Infect Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1093\/cid\/ciw017","article-title":"Body composition changes after initiation of raltegravir or protease inhibitors: ACTG A5260s","volume":"62","author":"McComsey","year":"2016","journal-title":"Clin Infect Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3389\/fendo.2018.00705","article-title":"The impact of weight gain during HIV treatment on risk of pre-diabetes, diabetes mellitus, cardiovascular disease, and mortality","volume":"9","author":"Kumar","year":"2018","journal-title":"Front Endocrinol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJM199901143400207","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e0147484","DOI":"10.1371\/journal.pone.0147484","article-title":"Pro-inflammatory markers in relation to cardiovascular disease in HIV infection. a systematic review","volume":"11","author":"Vos","year":"2016","journal-title":"PLoS ONE."},{"key":"B44","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/jama.2012.6698","article-title":"Arterial inflammation in patients with HIV","volume":"308","author":"Subramanian","year":"2012","journal-title":"JAMA."},{"key":"B45","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/infdis\/jir214","article-title":"Soluble CD163 made by monocyte\/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy","volume":"204","author":"Burdo","year":"2011","journal-title":"J Infect Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1080\/15284336.2017.1366001","article-title":"Soluble TWEAK may predict carotid atherosclerosis in treated HIV infection","volume":"18","author":"Dirajlal-Fargo","year":"2017","journal-title":"HIV Clin Trials."},{"key":"B47","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1097\/QAD.0b013e328351f756","article-title":"HIV infection induces age-related changes to monocytes and innate immune activation in young men that persist despite combination antiretroviral therapy","volume":"26","author":"Hearps","year":"2012","journal-title":"AIDS."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e55279","DOI":"10.1371\/journal.pone.0055279","article-title":"Age-associated changes in monocyte and innate immune activation markers occur more rapidly in HIV infected women","volume":"8","author":"Martin","year":"2013","journal-title":"PLoS ONE."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1093\/infdis\/jit025","article-title":"Long-term suppressive combined antiretroviral treatment does not normalize the serum level of soluble CD14","volume":"207","author":"Mendez-Lagares","year":"2013","journal-title":"J Infect Dis."},{"key":"B50","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/QAI.0000000000000559","article-title":"Viremic and virologically suppressed HIV infection increases age-related changes to monocyte activation equivalent to 12 and 4 years of aging, respectively","volume":"69","author":"Angelovich","year":"2015","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1093\/infdis\/jiu275","article-title":"Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection","volume":"210","author":"Wilson","year":"2014","journal-title":"J Infect Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1093\/infdis\/jit508","article-title":"Noncalcified coronary atherosclerotic plaque and immune activation in HIV-infected women","volume":"208","author":"Fitch","year":"2013","journal-title":"J Infect Dis."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1093\/infdis\/jir520","article-title":"Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients","volume":"204","author":"Burdo","year":"2011","journal-title":"J Infect Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1097\/QAD.0000000000000145","article-title":"Immunologic predictors of coronary artery calcium progression in a contemporary HIV cohort","volume":"28","author":"Baker","year":"2014","journal-title":"AIDS."},{"key":"B55","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1097\/QAD.0000000000000158","article-title":"Soluble CD14 is independently associated with coronary calcification and extent of subclinical vascular disease in treated HIV infection","volume":"28","author":"Longenecker","year":"2014","journal-title":"AIDS."},{"key":"B56","doi-asserted-by":"publisher","first-page":"e0155100","DOI":"10.1371\/journal.pone.0155100","article-title":"Relevance of interleukin-6 and D-dimer for serious non-AIDS morbidity and death among HIV-positive adults on suppressive antiretroviral therapy","volume":"11","author":"Grund","year":"2016","journal-title":"PLoS ONE."},{"key":"B57","doi-asserted-by":"publisher","first-page":"e44454","DOI":"10.1371\/journal.pone.0044454","article-title":"Inflammation, coagulation and cardiovascular disease in HIV-infected individuals","volume":"7","author":"Duprez","year":"2012","journal-title":"PLoS ONE."},{"key":"B58","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1186\/1471-2334-13-414","article-title":"The association of high-sensitivity c-reactive protein and other biomarkers with cardiovascular disease in patients treated for HIV: a nested case-control study","volume":"13","author":"De Luca","year":"2013","journal-title":"BMC Infect Dis."},{"key":"B59","doi-asserted-by":"publisher","first-page":"e000844","DOI":"10.1161\/JAHA.114.000844","article-title":"Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation","volume":"3","author":"Nordell","year":"2014","journal-title":"J Am Heart Assoc."},{"key":"B60","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1182\/blood-2009-03-210179","article-title":"Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation","volume":"115","author":"Funderburg","year":"2010","journal-title":"Blood."},{"key":"B61","doi-asserted-by":"publisher","first-page":"aam5441","DOI":"10.1126\/scitranslmed.aam5441","article-title":"Inflammatory monocytes expressing tissue factor drive SIV and HIV coagulopathy","volume":"9","author":"Schechter","year":"2017","journal-title":"Sci Transl Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"4599","DOI":"10.1182\/blood-2012-05-433946","article-title":"Shared monocyte subset phenotypes in HIV-1 infection and in uninfected subjects with acute coronary syndrome","volume":"120","author":"Funderburg","year":"2012","journal-title":"Blood."},{"key":"B63","doi-asserted-by":"publisher","first-page":"e365","DOI":"10.1371\/journal.pbio.0040365","article-title":"Human immunodeficiency virus impairs reverse cholesterol transport from macrophages","volume":"4","author":"Mujawar","year":"2006","journal-title":"PLoS Biol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10554-007-9278-9","article-title":"Characteristics of coronary plaques before angiographic progression determined by Multi-Slice CT","volume":"24","author":"Leber","year":"2008","journal-title":"Int J Cardiovasc Imaging."},{"key":"B65","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/ehjci\/jev325","article-title":"Characteristics of high-risk coronary plaques identified by computed tomographic angiography and associated prognosis: a systematic review and meta-analysis","volume":"17","author":"Thomsen","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging."},{"key":"B66","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1097\/QAD.0b013e3280108704","article-title":"Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses","volume":"20","author":"Hsue","year":"2006","journal-title":"AIDS."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1097\/QAD.0b013e32832d3b85","article-title":"Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study","volume":"23","author":"Grunfeld","year":"2009","journal-title":"AIDS."},{"key":"B68","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/eci.12780","article-title":"Subclinical atherosclerosis in low Framingham risk HIV patients","volume":"47","author":"Leon","year":"2017","journal-title":"Eur J Clin Invest."},{"key":"B69","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1086\/504719","article-title":"Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94\/NKG2C receptor in aviremic HIV-1-positive patients","volume":"194","author":"Guma","year":"2006","journal-title":"J Infect Dis."},{"key":"B70","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/QAD.0b013e3283328d1f","article-title":"Chronic HIV-1 viremia reverses NKG2A\/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection","volume":"24","author":"Brunetta","year":"2010","journal-title":"AIDS."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1093\/infdis\/jiw463","article-title":"Inflammatory Function of CX3CR1+ CD8+ T cells in treated HIV infection is modulated by platelet interactions","volume":"214","author":"Mudd","year":"2016","journal-title":"J Infect Dis."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1093\/infdis\/jis276","article-title":"Cytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected women","volume":"205","author":"Parrinello","year":"2012","journal-title":"J Infect Dis."},{"key":"B73","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/hiv.12672","article-title":"Coronary artery calcium and intima-media thickness are associated with level of cytomegalovirus immunoglobulin G in HIV-infected patients","volume":"20","author":"Knudsen","year":"2019","journal-title":"HIV Med."},{"key":"B74","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/QAD.0b013e328333ea9e","article-title":"Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men","volume":"24","author":"Lo","year":"2010","journal-title":"AIDS."},{"key":"B75","doi-asserted-by":"publisher","first-page":"458","DOI":"10.7326\/M13-1754","article-title":"Associations between HIV infection and subclinical coronary atherosclerosis","volume":"160","author":"Post","year":"2014","journal-title":"Ann Intern Med."},{"key":"B76","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1093\/eurheartj\/ehy163","article-title":"Subclinical coronary artery disease in Swiss HIV-positive and HIV-negative persons","volume":"39","author":"Tarr","year":"2018","journal-title":"Eur Heart J."},{"key":"B77","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.atherosclerosis.2015.03.019","article-title":"High prevalence at computed coronary tomography of non-calcified plaques in asymptomatic HIV patients treated with HAART: a meta-analysis","volume":"240","author":"D'Ascenzo","year":"2015","journal-title":"Atherosclerosis."},{"key":"B78","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2967\/jnmt.115.155960","article-title":"99mTc-Tilmanocept: a novel molecular agent for lymphatic mapping and sentinel lymph node localization","volume":"43","author":"Surasi","year":"2015","journal-title":"J Nucl Med Technol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1093\/infdis\/jix095","article-title":"Application of a Novel CD206+ macrophage-specific arterial imaging strategy in HIV-infected individuals","volume":"215","author":"Zanni","year":"2017","journal-title":"J Infect Dis."},{"key":"B80","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13550-019-0474-0","article-title":"Targeting mannose receptor expression on macrophages in atherosclerotic plaques of apolipoprotein E-knockout mice using (68)Ga-NOTA-anti-MMR nanobody: non-invasive imaging of atherosclerotic plaques","volume":"9","author":"Varasteh","year":"2019","journal-title":"EJNMMI Res."},{"key":"B81","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1476-9255-9-26","article-title":"18FDG PET-CT imaging detects arterial inflammation and early atherosclerosis in HIV-infected adults with cardiovascular disease risk factors","volume":"9","author":"Yarasheski","year":"2012","journal-title":"J Inflamm."},{"key":"B82","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1097\/QAI.0000000000000138","article-title":"Increased arterial inflammation relates to high-risk coronary plaque morphology in HIV-infected patients","volume":"66","author":"Tawakol","year":"2014","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B83","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1016\/S2352-3018(14)00032-0","article-title":"Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial","volume":"2","author":"Lo","year":"2015","journal-title":"Lancet HIV."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1093\/infdis\/jiu012","article-title":"Effect of 24 weeks of statin therapy on systemic and vascular inflammation in HIV-infected subjects receiving antiretroviral therapy","volume":"209","author":"Eckard","year":"2014","journal-title":"J Infect Dis."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1056\/NEJM200010193431603","article-title":"Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group","volume":"343","author":"Packard","year":"2000","journal-title":"N Engl J Med."},{"key":"B86","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/QAI.0000000000000478","article-title":"Rosuvastatin reduces vascular inflammation and T-cell and monocyte activation in HIV-infected subjects on antiretroviral therapy","volume":"68","author":"Funderburg","year":"2015","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B87","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/0006-291X(91)90942-Z","article-title":"Oxidation of cholesterol moiety of low density lipoprotein in the presence of human endothelial cells or Cu+2 ions: identification of major products and their effects","volume":"176","author":"Bhadra","year":"1991","journal-title":"Biochem Biophys Res Commun."},{"key":"B88","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1161\/01.ATV.11.3.482","article-title":"Varying susceptibility of different low density lipoproteins to oxidative modification","volume":"11","author":"Jialal","year":"1991","journal-title":"Arterioscler Thromb."},{"key":"B89","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0022-2275(20)41191-5","article-title":"Macrophage-mediated oxidation of extracellular low density lipoprotein requires an initial binding of the lipoprotein to its receptor","volume":"35","author":"Aviram","year":"1994","journal-title":"J Lipid Res."},{"key":"B90","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/QAI.0000000000000566","article-title":"Oxidized LDL levels are increased in HIV infection and may drive monocyte activation","volume":"69","author":"Zidar","year":"2015","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B91","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1310\/7381-M1YD-RTV5-4RYT","article-title":"Concentration of circulating oxidized LDL in HIV-infected patients treated with antiretroviral agents: relation to HIV-related lipodystrophy","volume":"7","author":"Duong","year":"2006","journal-title":"HIV Clin Trials."},{"key":"B92","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1468-1293.2009.00766.x","article-title":"Nonconcordance between subclinical atherosclerosis and the calculated Framingham risk score in HIV-infected patients: relationships with serum markers of oxidation and inflammation","volume":"11","author":"Parra","year":"2010","journal-title":"HIV Med."},{"key":"B93","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1097\/QAD.0000000000000946","article-title":"Serum oxidized low-density lipoprotein decreases in response to statin therapy and relates independently to reductions in coronary plaque in patients with HIV","volume":"30","author":"Nou","year":"2016","journal-title":"AIDS."},{"key":"B94","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrcardio.2009.228","article-title":"Monocytes in atherosclerosis: subsets and functions","volume":"7","author":"Woollard","year":"2010","journal-title":"Nat Rev Cardiol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.atherosclerosis.2017.09.032","article-title":"Shift of monocyte subsets along their continuum predicts cardiovascular outcomes","volume":"266","author":"Cappellari","year":"2017","journal-title":"Atherosclerosis."},{"key":"B96","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1126\/science.1175202","article-title":"Identification of splenic reservoir monocytes and their deployment to inflammatory sites","volume":"325","author":"Swirski","year":"2009","journal-title":"Science."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1182\/blood-2017-03-771261","article-title":"Circulatory and maturation kinetics of human monocyte subsets in vivo","volume":"130","author":"Tak","year":"2017","journal-title":"Blood."},{"key":"B98","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/29788","article-title":"Decreased lesion formation in CCR2-\/- mice reveals a role for chemokines in the initiation of atherosclerosis","volume":"394","author":"Boring","year":"1998","journal-title":"Nature."},{"key":"B99","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1172\/JCI28549","article-title":"Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques","volume":"117","author":"Tacke","year":"2007","journal-title":"J Clin Invest."},{"key":"B100","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1172\/JCI29950","article-title":"Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata","volume":"117","author":"Swirski","year":"2007","journal-title":"J Clin Invest."},{"key":"B101","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1161\/CIRCULATIONAHA.113.001278","article-title":"Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice","volume":"127","author":"Cipriani","year":"2013","journal-title":"Circulation."},{"key":"B102","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1084\/jem.20070885","article-title":"The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions","volume":"204","author":"Nahrendorf","year":"2007","journal-title":"J Exp Med."},{"key":"B103","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/icb.2013.84","article-title":"Associations between surface markers on blood monocytes and carotid atherosclerosis in HIV-positive individuals","volume":"92","author":"Westhorpe","year":"2014","journal-title":"Immunol Cell Biol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/S0140-6736(96)10178-1","article-title":"Unique monocyte subset in patients with AIDS dementia","volume":"349","author":"Pulliam","year":"1997","journal-title":"Lancet."},{"key":"B105","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.1002\/eji.1830251232","article-title":"CD14lowCD16high: a cytokine-producing monocyte subset which expands during human immunodeficiency virus infection","volume":"25","author":"Thieblemont","year":"1995","journal-title":"Eur J Immunol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1086\/518443","article-title":"CD16+ monocyte subset preferentially harbors HIV-1 and is expanded in pregnant Malawian women with Plasmodium falciparum malaria and HIV-1 infection","volume":"196","author":"Jaworowski","year":"2007","journal-title":"J Infect Dis."},{"key":"B107","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1046\/j.1365-2249.2000.01201.x","article-title":"Impact of highly active anti-retroviral therapy (HAART) on cytokine production and monocyte subsets in HIV-infected patients","volume":"120","author":"Amirayan-Chevillard","year":"2000","journal-title":"Clin Exp Immunol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"731","DOI":"10.3389\/fimmu.2017.00731","article-title":"Persistence of activated and adaptive-like NK Cells in HIV(+) individuals despite 2 years of suppressive combination antiretroviral therapy","volume":"8","author":"Hearps","year":"2017","journal-title":"Front Immunol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1086\/500367","article-title":"Normal CD16 expression and phagocytosis of Mycobacterium avium complex by monocytes from a current cohort of HIV-1-infected patients","volume":"193","author":"Jaworowski","year":"2006","journal-title":"J Infect Dis."},{"key":"B110","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.4049\/jimmunol.154.8.4099","article-title":"The adhesion molecules used by monocytes for migration across endothelium include CD11a\/CD18, CD11b\/CD18, and VLA-4 on monocytes and ICAM-1, VCAM-1, and other ligands on endothelium","volume":"154","author":"Meerschaert","year":"1995","journal-title":"J Immunol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"4855","DOI":"10.4049\/jimmunol.1602175","article-title":"The upregulation of integrin alphaDbeta2 (CD11d\/CD18) on inflammatory macrophages promotes macrophage retention in vascular lesions and development of atherosclerosis","volume":"198","author":"Aziz","year":"2017","journal-title":"J Immunol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/S0735-1097(97)00424-5","article-title":"Increased expression of neutrophil and monocyte adhesion molecules LFA-1 and Mac-1 and their ligand ICAM-1 and VLA-4 throughout the acute phase of myocardial infarction: possible implications for leukocyte aggregation and microvascular plugging","volume":"31","author":"Meisel","year":"1998","journal-title":"J Am Coll Cardiol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"11779","DOI":"10.1073\/pnas.0403259101","article-title":"Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques","volume":"101","author":"Llodra","year":"2004","journal-title":"Proc Natl Acad Sci USA."},{"key":"B114","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/MOL.0b013e32830d5f09","article-title":"Emigration of monocyte-derived cells to lymph nodes during resolution of inflammation and its failure in atherosclerosis","volume":"19","author":"Randolph","year":"2008","journal-title":"Curr Opin Lipidol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"C555","DOI":"10.1152\/ajpcell.00177.2002","article-title":"Uptake of modified low-density lipoproteins alters actin distribution and locomotor forces in macrophages","volume":"284","author":"Zerbinatti","year":"2003","journal-title":"Am J Physiol Cell Physiol."},{"key":"B116","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0022-2275(20)31999-4","article-title":"Cholesterol delivered to macrophages by oxidized low density lipoprotein is sequestered in lysosomes and fails to efflux normally","volume":"41","author":"Dhaliwal","year":"2000","journal-title":"J Lipid Res."},{"key":"B117","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0014-4800(90)90046-G","article-title":"Early atherogenesis in White Carneau pigeons: effect of a short-term regression diet","volume":"53","author":"Jerome","year":"1990","journal-title":"Exp Mol Pathol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/icb.2015.26","article-title":"Inflammation-induced foam cell formation in chronic inflammatory disease","volume":"93","author":"Angelovich","year":"2015","journal-title":"Immunol Cell Biol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"e104039","DOI":"10.1371\/journal.pone.0104039","article-title":"HIV-derived ssRNA binds to TLR8 to induce inflammation-driven macrophage foam cell formation","volume":"9","author":"Bernard","year":"2014","journal-title":"PLoS ONE."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1038\/nm1511","article-title":"Microbial translocation is a cause of systemic immune activation in chronic HIV infection","volume":"12","author":"Brenchley","year":"2006","journal-title":"Nat Med."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1086\/597476","article-title":"Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection","volume":"199","author":"Jiang","year":"2009","journal-title":"J Infect Dis."},{"key":"B122","doi-asserted-by":"publisher","first-page":"28870","DOI":"10.1074\/jbc.M114.583591","article-title":"HIV-1 protein Nef inhibits activity of ATP-binding cassette transporter A1 by targeting endoplasmic reticulum chaperone calnexin","volume":"289","author":"Jennelle","year":"2014","journal-title":"J Biol Chem."},{"key":"B123","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1084\/jem.176.3.819","article-title":"Monocyte-selective transendothelial migration: dissection of the binding and transmigration phases by an in vitro assay","volume":"176","author":"Muller","year":"1992","journal-title":"J Exp Med."},{"key":"B124","doi-asserted-by":"publisher","first-page":"e56293","DOI":"10.3791\/56293","article-title":"Quantification of monocyte transmigration and foam cell formation from individuals with chronic inflammatory conditions","volume":"128","author":"Angelovich","year":"2017","journal-title":"J Vis Exp"},{"key":"B125","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1002\/jlb.66.5.698","article-title":"Migration of leukocytes across endothelium and beyond: molecules involved in the transmigration and fate of monocytes","volume":"66","author":"Muller","year":"1999","journal-title":"J Leukoc Biol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1097\/QAD.0000000000000739","article-title":"Monocytes from HIV-infected individuals show impaired cholesterol efflux and increased foam cell formation after transendothelial migration","volume":"29","author":"Maisa","year":"2015","journal-title":"AIDS."},{"key":"B127","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.exger.2016.04.006","article-title":"Ex vivo foam cell formation is enhanced in monocytes from older individuals by both extrinsic and intrinsic mechanisms","volume":"80","author":"Angelovich","year":"2016","journal-title":"Exp Gerontol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/j.1474-9726.2012.00851.x","article-title":"Aging is associated with chronic innate immune activation and dysregulation of monocyte phenotype and function","volume":"11","author":"Hearps","year":"2012","journal-title":"Aging Cell."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1194\/jlr.M002410","article-title":"TNF-alpha decreases ABCA1 expression and attenuates HDL cholesterol efflux in the human intestinal cell line Caco-2","volume":"51","author":"Field","year":"2010","journal-title":"J Lipid Res."},{"key":"B130","doi-asserted-by":"crossref","first-page":"11811","DOI":"10.1016\/S0021-9258(19)50272-1","article-title":"CD36 is a receptor for oxidized low density lipoprotein","volume":"268","author":"Endemann","year":"1993","journal-title":"J Biol Chem."},{"key":"B131","doi-asserted-by":"publisher","first-page":"49982","DOI":"10.1074\/jbc.M209649200","article-title":"Scavenger receptors class A-I\/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages","volume":"277","author":"Kunjathoor","year":"2002","journal-title":"J Biol Chem."},{"key":"B132","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.tcm.2003.09.004","volume":"14","author":"Nicholson","year":"2004","journal-title":"Trends Cardiovasc Med."},{"key":"B133","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1097\/QAD.0000000000001238","article-title":"Oxidized lipoproteins are associated with markers of inflammation and immune activation in HIV-1 infection","volume":"30","author":"Kelesidis","year":"2016","journal-title":"AIDS."},{"key":"B134","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1097\/QAD.0000000000001642","article-title":"Dysfunctional high-density lipoprotein from HIV+ individuals promotes monocyte-derived foam cell formation in vitro","volume":"31","author":"Angelovich","year":"2017","journal-title":"AIDS."},{"key":"B135","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.atherosclerosis.2015.08.036","article-title":"HIV infection induces structural and functional changes in high density lipoproteins","volume":"243","author":"Siegel","year":"2015","journal-title":"Atherosclerosis."},{"key":"B136","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1161\/01.RES.0000146094.59640.13","article-title":"Antiinflammatory properties of HDL","volume":"95","author":"Barter","year":"2004","journal-title":"Circ Res."},{"key":"B137","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1194\/jlr.R400001-JLR200","article-title":"The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL","volume":"45","author":"Navab","year":"2004","journal-title":"J Lipid Res."},{"key":"B138","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1161\/01.ATV.18.10.1617","article-title":"Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase\/paraoxonase activities: selective action of human paraoxonase allozymes Q and R","volume":"18","author":"Aviram","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1172\/JCI118359","article-title":"Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein","volume":"96","author":"Watson","year":"1995","journal-title":"J Clin Invest."},{"key":"B140","first-page":"143","article-title":"Anti-Inflammatory properties of paraoxonase-1 in atherosclerosis","volume-title":"Paraoxonases in Inflammation, Infection and Toxicology","author":"Mackness","year":"2009"},{"key":"B141","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1161\/01.ATV.0000060462.35946.B3","article-title":"Human serum paraoxonase 1 decreases macrophage cholesterol biosynthesis: possible role for its phospholipase-A2-like activity and lysophosphatidylcholine formation","volume":"23","author":"Rozenberg","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/00041433-200406000-00006","article-title":"High density lipoproteins in the intersection of diabetes mellitus, inflammation and cardiovascular disease","volume":"15","author":"Rohrer","year":"2004","journal-title":"Curr Opin Lipidol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/MOL.0b013e3282364a17","article-title":"The paradox of dysfunctional high-density lipoprotein","volume":"18","author":"Ansell","year":"2007","journal-title":"Curr OpinLipidol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.immuni.2010.08.012","article-title":"Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors","volume":"33","author":"Cros","year":"2010","journal-title":"Immunity."},{"key":"B145","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/cvr\/cvv147","article-title":"Monocyte trafficking across the vessel wall","volume":"107","author":"Gerhardt","year":"2015","journal-title":"Cardiovasc Res."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01378\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T15:22:42Z","timestamp":1694964162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01378\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,19]]},"references-count":145,"alternative-id":["10.3389\/fimmu.2019.01378"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01378","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,19]]},"article-number":"1378"}}